DCT

1:20-cv-00019

Boehringer Ingelheim Pharma Inc v. Mylan Pharma Inc

General

Filed

02/05/20

Cause of ActionPatent Infringement

SectorBiotech

StatusOpen

Patent Owner

Operating Company (W)

PACER

Nature of Suit830 Patent

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Judge	Period	PO Win Rate
Thomas S. Kleeh	01/24/22 - now	50%
John P. Bailey	06/15/20 - 01/24/22	50%

Plaintiff

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Party

Name	Ratings
Boehringer-Ingelheim Pharmaceuticals Inc	L4 C
Boehringer-Ingelheim Pharma GmbH	L4 C
Boehringer Ingelheim Intl GmbH	L4 C
Boehringer-Ingelheim Corp	L2 D

No Parties

Attorney

Name	Ratings
Kirkland & Ellis LLP	L5 A
Patrick J. Coyne	L5 A
Neal S. Cohen	L5 A
Peter Kinsella	L5 A
Scott E. Holwick	L5 A
Robert D. Bajefsky	L5 A
Jennifer S. Swan	L5 A
Aaron M. Raphael	L5 A
Hugh S. Balsam	L5 A
Lisa A. Jakob	L5 A
David A. Nelson	L5 A
Steven M. Bauer	L5 A
Richard W. Hanes	L5 A
Michael J. Schaengold	L5 A
Robert J. Koch	L5 A
Schrader BYRD & Companion PLLCLocal	L5 A
Scott J. Popma	L5 A
Angie M. Hankins	L5 A
Carey Douglas Kessler & Ruby PLLCLocal	L5 A
Timothy J. Schutz	L5 A
Marc R. Labgold	L5 A
Kevin M. Bell	L5 A

No Attorneys

Defendant

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Party

No Parties

Attorney

No Attorneys